To sum up, inventors from the United States took the dominant positions in the considered technology.
American and Chinese IP law firms were the worldwide leaders in prosecuting pharmaceuticals cases. While the US ones handled patent filings mostly coming from local applicants, their Asian colleagues had a somewhat more balanced portfolio of domestic and inbound work shares.
In Europe, conventionally, German ann British associates were the key players and prosecuted mainly filings they received from abroad or, more precisely, from the US. They were followed by French associates who received pharma-related applications from domestic clients.
In addition, the associates from the world’s most populated countries, such as Brazil, Canada, Russia, and Australia, were also among the most prominent in terms of volumes of prosecuted pharma-related cases.